Allakos Inc. financial data

Symbol
ALLK on Nasdaq
Industry
Pharmaceutical Preparations
Location
825 Industrial Road, Suite 500, San Carlos, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 444 % -55%
Debt-to-equity 63.4 % +148%
Return On Equity -166 % -167%
Return On Assets -102 % -105%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 89.3M shares +2.14%
Common Stock, Shares, Outstanding 89.3M shares +2.14%
Entity Public Float 288M USD +138%
Common Stock, Value, Issued 89K USD +2.3%
Weighted Average Number of Shares Outstanding, Basic 89M shares +2.19%
Weighted Average Number of Shares Outstanding, Diluted 89M shares +2.19%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 119M USD -10.2%
General and Administrative Expense 40.2M USD -10.3%
Operating Income (Loss) -186M USD -5.16%
Net Income (Loss) Attributable to Parent -179M USD -7.59%
Earnings Per Share, Basic -2.04 USD/shares -40.7%
Earnings Per Share, Diluted -2.04 USD/shares -40.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.4M USD -85.2%
Marketable Securities, Current 82.3M USD -33.3%
Cash, Cash Equivalents, and Short-term Investments 92.7M USD -52.2%
Assets, Current 97.2M USD -55.5%
Property, Plant and Equipment, Net 15.7M USD -55%
Operating Lease, Right-of-Use Asset 9.88M USD -59.1%
Other Assets, Noncurrent 1.67M USD -72.6%
Assets 124M USD -56.1%
Accounts Payable, Current 3.96M USD +333%
Employee-related Liabilities, Current 5.67M USD
Accrued Liabilities, Current 12M USD -46.7%
Liabilities, Current 16M USD -31.9%
Operating Lease, Liability, Noncurrent 35.7M USD -8.44%
Liabilities 51.7M USD -17.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 334K USD
Retained Earnings (Accumulated Deficit) -1.23B USD -16.9%
Stockholders' Equity Attributable to Parent 72.7M USD -67.1%
Liabilities and Equity 124M USD -56.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -32.5M USD -7.97%
Net Cash Provided by (Used in) Financing Activities 132K USD -90.9%
Net Cash Provided by (Used in) Investing Activities 9.03M USD -74.4%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 89.3M shares +2.14%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -23.4M USD -452%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 11.9M USD -83.4%
Deferred Tax Assets, Valuation Allowance 374M USD +13.8%
Deferred Tax Assets, Gross 381M USD +12.9%
Operating Lease, Liability 39M USD -6.62%
Payments to Acquire Property, Plant, and Equipment 4K USD -98.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -178M USD -7.34%
Lessee, Operating Lease, Liability, to be Paid 56.2M USD -11.1%
Property, Plant and Equipment, Gross 25.1M USD -47.5%
Operating Lease, Liability, Current 3.29M USD +19%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.51M USD +3.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.29M USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 17.2M USD -19.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.73M USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 247M USD +9.42%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 15M USD +13.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.96M USD +3%
Operating Lease, Payments 1.8M USD +5.88%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 4.49M USD -26.1%
Deferred Tax Assets, Net of Valuation Allowance 6.59M USD -23.7%
Share-based Payment Arrangement, Expense 29.9M USD -25.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%